Edwards Lifesciences Corporation (NYSE:EW) : The value of composite uptick trades was $21.44 million, whereas, the value of composite downtick trades was $23.74 million. The uptick to downtick ratio stood at 0.9 with a negative money flow of ($2.3) Million during Wednesdays trading session. The block trades money flow was negative ($2.95 million).The uptick to the downtick ratio of 0.38 in block trades signals that the large investors have utilized the rise in the stock to sell.The uptick transaction value stood at $1.81 million. The transaction of the trades on downticks amounted to $4.77 million, which confirms investors selling on the strength of price. Edwards Lifesciences Corporation (NYSE:EW) gained 166 cents at $96.63, an increase of 1.75% over the previous days close.
In an insider trading activity, Mussallem Michael A, director officer (Chairman & CEO) of Edwards Lifesciences Corp, unloaded 49,100 shares at an average price of $102.25 on June 8, 2016. The total amount of the transaction was worth $5,020,475, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing. Currently the company Insiders own 2.37% of Edwards Lifesciences Corporation shares according to the proxy statements. Institutional Investors own 87.19% of Edwards Lifesciences Corporation shares.
The company shares have rallied 32.27% from its 1 Year high price. On Apr 27, 2016, the shares registered one year high at $112.00 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $100.36 and the 200 Day Moving Average price is recorded at $91.60. Edwards Lifesciences Corporation (NYSE:EW): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $96.19 and $95.49 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $97.18. The buying momentum continued till the end and the stock did not give up its gains. It closed at $96.91, notching a gain of 2.04% for the day. The total traded volume was 2,390,827 . The stock had closed at $94.97 on the previous day.
Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. The Company develops hemodynamic monitoring systems used to measure a patients cardiovascular function in the hospital setting. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by the its Critical Care products. The Companys products and technologies it offers to treat advanced cardiovascular disease are categorized into three main areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.